Clinical case of Susac syndrome in a pregnant woman-Reference-Cited by-同舟云学术

Clinical case of Susac syndrome in a pregnant woman

Published:2021-03-28 Issue:4 Volume: Page:282-288
ISSN:2074-6822
Container-title:Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
language:ru
Short-container-title:

Author:

Zakharycheva Tatyana Adolfovna¹^ORCID,Otteva Elvira Nikolaevna²,Shirokova Aleksandra Sergeevna³^ORCID,Litvinova O. V.⁴,Polyakov A. G.⁴,Snitko V. A.⁴,Sobulyak V. O.⁴,Chekurina S. L.⁴,Yaitskaya E. O.⁴,Syomova V. V.⁴

Affiliation:

1. Institute of Continuing Professional Education and Accreditation, FSBEI HE Far Eastern State Medical University of the Ministry of Health of the Russian Federation, Khabarovsk, Regional Сlinical hospital № 2 of Ministry of Healthcare of Khabarovsk region

2. SBEI FPE Institute for Advanced Training of Healthcare Professionals of the Khabarovsk Region, Khabarovsk, Regional Сlinical hospital № 1 named after professor S. P. Sergeev of Ministry of Healthcare of Khabarovsk region

3. RSBHI Regional Diagnostic Center «Vivea» of the Ministry of Health of the Khabarovsk Region, Regional State Budgetary Healthcare Institution Сonsultative Diagnostic Center «Vivea» of the Ministry of Healthcare of Khabarovsk region

4. Regional Сlinical hospital № 2 of Ministry of Healthcare of Khabarovsk region

Abstract

A clinical case of a rare disease — Susak’s syndrome — in a 24-year-old patient is presented. The disease developed during pregnancy and was accompanied by vestibulo-ataxic and visual disturbances. The diagnosis was established based on the results of clinical and laboratory-instrumental examination — the presence of microangiopathy with predominant damage to the arterioles of the cochlea, retina and brain. The diagnosis was established according to the results of a clinical study and the results of neuroimaging — microangiopathy with a predominant lesion of the arterioles of the cochlea, retina and brain. The response to glucocorticosteroid therapy was obtained. The possible role of the SARS-CoV-2 beta coronavirus in the genesis of the disease is being discussed. Currently, the patient is under the supervision of a neurologist and a rheumatologist, taking prednisone.

Publisher

PANORAMA Publishing House

Reference15 articles.

1. Jarius S., Kleffner I., Dorr J. M. et al. Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study // J. Neuroinflammation. 2014; 11 (1):46–50.

2. Rennebohm R. M., Egan R. A., Susac J. O. Treatment of Susac’s syndrome // Curr. Treat. Options Neurol. 2008; 10 (1):67–74.

3. Bucciarelli S., Cervera R., Martinez M. et al. Susac’s syndrome or catastrophic antiphospholipid syndrome // Lupus. 2004; 3:607–608.

4. Dorr J. M., Krautwald S., Wildemann B. et al. Characteristics of Susac syndrome: a review of all reported cases //Nat. Rev. Neurol. 2013; 9 (6):307–316.

5. Martinet N., Fardeau C., Adam R. et al. Fluorescein and indocyanine green angiographies in Susac’s syndrome // Retina. 2007; 27:1238–1242.